文献速递肿瘤 PET/CT放射性药物与辐射防护

[18F]FDG PET/CT 验证队列:可排除肾移植受者急性排斥反应

[18F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-06-30

该前瞻性验证队列纳入79例因疑似急性排斥反应行移植肾活检的成人肾移植受者,共完成86次[18F]FDG PET/CT。以肾实质mSUVmean阈值1.6区分急性排斥反应与非病理状态时,敏感度100%、特异度30%,曲线下面积0.86,提示该检查可能有助于无创性避免不必要的移植肾活检。

要点

  • 阈值1.6排除急性排斥反应的敏感度为100%,特异度仅30%。
  • mSUVmean在正常、交界性、急性排斥反应组间差异有统计学意义(p<0.0001)。
  • 该检查可能帮助肾移植受者减少不必要的移植肾活检。

核心结论

  • [18F]FDG PET/CT可能有助于无创性避免急性肾损伤肾移植受者中不必要的移植肾活检。

研究设计与样本

  • 前瞻性验证队列,纳入79例因疑似急性排斥反应行移植肾活检的成人肾移植受者,共完成86次[18F]FDG PET/CT;排除活检证实的多瘤病毒BK肾病7例。
  • PET/CT在注射254.4 ± 30.4 MBq [18F]FDG后192 ± 18 min进行,测量移植肾上、下极的SUVmean。
  • 采用单因素方差分析(ANOVA)和Tukey学生化极差检验,并绘制ROC曲线区分急性排斥反应与非病理状态(正常+交界性)。

主要发现

  • 队列中位年龄55 [43; 63]岁,男/女比为47/39,平均eGFR为31.9 ± 14.6 ml/min/1.73m2。
  • 活检分组:正常54例、交界性9例、急性排斥反应14例、其他2例。
  • mSUVmean中位数[最小值; 最大值]在正常组为1.72 [1.02; 2.07],交界性组为1.97 [1.55; 2.11],急性排斥反应组为2.13 [1.65, 3.12],其他组为1.84 [1.57; 2.12]。
  • ANOVA显示各组间mSUVmean差异有统计学意义(F = 13.25,p < 0.0001)。
  • ROC曲线下面积为0.86;阈值1.6对应的敏感度为100%,特异度为30%。

关键数值与推荐

  • 以肾实质mSUVmean阈值1.6区分急性排斥反应与非病理状态时,敏感度100%、特异度30%,ROC曲线下面积0.86。

临床怎么用

  • 对于疑似急性排斥反应的肾移植受者,[18F]FDG PET/CT的mSUVmean低于1.6时可高敏感度排除急性排斥反应,可能减少不必要的移植肾活检。
  • 因阈值1.6的特异度较低,高于该值不能直接诊断急性排斥反应,仍需结合活检等进一步评估。

局限性

  • 原文未报告本研究的具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: [18F]FDG PET/CT may predict the absence of acute allograft rejection (AR) in kidney transplant recipients (KTRs) with acute kidney injury (AKI). Still, the proposed threshold of 1.6 of the mean of mean standardized uptake values (mSUVmean) in the renal parenchyma needs validation. METHODS: We prospectively performed 86 [18F]FDG PET/CT in 79 adult KTRs who underwent per-cause transplant biopsy for suspected AR. Biopsy-proven polyoma BK nephropathies (n = 7) were excluded. PET/CT was performed 192 ± 18 min after administration of 254.4 ± 30.4 MBq of [18F]FDG. The SUVmean was measured in both upper and lower poles of the renal allograft. One-way analysis of variance (ANOVA) and Tukey's studentized range test were sequentially performed. The receiver operating characteristic (ROC) curve was drawn to discriminate "AR" from non-pathological ("normal" + "borderline") conditions. RESULTS: The median age of the cohort was 55 [43; 63] years, with M/F gender ratio of 47/39. The mean eGFR was 31.9 ± 14.6 ml/min/1.73m2. Biopsies were categorized in 4 groups: "normal" (n = 54), "borderline" (n = 9), "AR" (n = 14), or "others" (n = 2). The median [min; max] mSUVmean reached 1.72 [1.02; 2.07], 1.97 [1.55; 2.11], 2.13 [1.65, 3.12], and 1.84 [1.57; 2.12] in "normal," "borderline," "AR," and "others" groups, respectively. ANOVA demonstrated a significant difference of mSUVmean among groups (F = 13.25, p < 0.0001). The ROC area under the curve was 0.86. Test sensitivity and specificity corresponding to the threshold value of 1.6 were 100% and 30%, respectively. CONCLUSION: [18F]FDG PET/CT may help noninvasively prevent inessential transplant biopsies in KTR with AKI.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lovinfosse P, Weekers L, Pottel H, et al. [18F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. Eur J Nucl Med Mol Imaging. 2021. PMID: 34191101. doi:10.1007/s00259-021-05467-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。